Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular classification of estrogens.

V C Jordan1, J M Schafer, A S Levenson

  • 1Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, Illinois 60611, USA. vcjordan@northwestern.edu

Cancer Research
|September 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype.

Oncogene·2008
Same author

Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor alpha.

British journal of cancer·2002
Same author

Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells.

The Journal of steroid biochemistry and molecular biology·2001
Same author

Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351.

The Journal of steroid biochemistry and molecular biology·2001
Same author

Selective oestrogen receptor modulation: molecular pharmacology for the millennium.

European journal of cancer (Oxford, England : 1990)·2000
Same author

Selective oestrogen receptor modulation: molecular pharmacology for the millennium.

European journal of cancer (Oxford, England : 1990)·2000
Same journal

Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis.

Cancer research·2026
Same journal

SEPTIN7 Enhances Tumorgenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling.

Cancer research·2026
Same journal

TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

Cancer research·2026
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
See all related articles

Different estrogens induce distinct estrogen receptor alpha (ER) conformations, influencing gene activation. This suggests classifying estrogens based on their ER interaction may predict selective actions and carcinogenic potential.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Estrogens play crucial roles in target tissues like the uterus, breast, and pituitary gland, where hormone-responsive tumors frequently arise.
  • The precise conformational changes induced in estrogen receptor alpha (ER) by various estrogens remain incompletely understood.
  • Understanding ER conformation is vital for deciphering selective estrogen actions and carcinogenic potential.

Purpose of the Study:

  • To investigate whether different estrogens induce distinct conformations of estrogen receptor alpha (ER).
  • To explore the impact of these distinct ER conformations on the activation of the transforming growth factor alpha (TGF-alpha) gene.
  • To propose a classification of estrogens based on their ER interaction and potential functional outcomes.

Main Methods:

Related Experiment Videos

  • Utilized a novel in vitro assay to assess TGF-alpha gene activation in MDA-MB-231 cells expressing specific ER variants (D351 ER and D351G ER).
  • Tested the effects of three distinct estrogen types: estradiol, diethylstilbestrol, and a triphenylethylene (TPE) derivative.
  • Employed computer molecular modeling to interpret experimental data and elucidate ER-ligand interactions.

Main Results:

  • Flat estrogens (estradiol, diethylstilbestrol) activated TGF-alpha via the canonical activating function 2 (AF2) domain, facilitating SRC-1 binding.
  • The TPE derivative, however, activated TGF-alpha through an alternative pathway (AF2b), as evidenced by differential activation of D351 ER but not D351G ER.
  • This differential activation highlights distinct ER conformational responses to different estrogen structures.

Conclusions:

  • Propose the existence of two distinct classes of estrogens based on their ability to form different ER complexes.
  • These distinct ER complexes may recruit different coactivators, leading to varied downstream effects.
  • Estrogen structure dictates ER conformation, influencing selective actions and potentially carcinogenic outcomes of phytoestrogens and xenoestrogens.